BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8230275)

  • 1. Elevated estrogen 16 alpha-hydroxylase activity: is this a genotoxic or nongenotoxic biomarker in human breast cancer risk?
    Nebert DW
    J Natl Cancer Inst; 1993 Dec; 85(23):1888-91. PubMed ID: 8230275
    [No Abstract]   [Full Text] [Related]  

  • 2. Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk.
    Osborne MP; Bradlow HL; Wong GY; Telang NT
    J Natl Cancer Inst; 1993 Dec; 85(23):1917-20. PubMed ID: 8230281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction and inhibition of estradiol hydroxylase activities in MCF-7 human breast cancer cells in culture.
    Niwa T; Bradlow HL; Fishman J; Swaneck GE
    Steroids; 1990 Jul; 55(7):297-302. PubMed ID: 2219196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of estradiol 2- and 16-alpha-hydroxylase activities in MCF-7 human breast cancer cells in culture using radiometric analysis.
    Niwa T; Bradlow HL; Fishman J; Swaneck GE
    J Steroid Biochem; 1989 Aug; 33(2):311-4. PubMed ID: 2770303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased estrogen-16 alpha-hydroxylase activity in women with breast and endometrial cancer.
    Fishman J; Schneider J; Hershcope RJ; Bradlow HL
    J Steroid Biochem; 1984 Apr; 20(4B):1077-81. PubMed ID: 6727352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of estradiol by human breast cancer.
    Abul-Hajj YJ; Thijssen JH; Blankenstein MA
    Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1171-8. PubMed ID: 3416901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase regulation and breast cancer.
    Reed MJ; Purohit A
    Clin Endocrinol (Oxf); 2001 May; 54(5):563-71. PubMed ID: 11380485
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of estrogen metabolism on proliferation of human breast cancer.
    Imoto S; Mitani F; Enomoto K; Fujiwara K; Ikeda T; Kitajima M; Ishimura Y
    Breast Cancer Res Treat; 1997 Jan; 42(1):57-64. PubMed ID: 9116318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological effect of estrogen metabolites in human breast cancer].
    Imoto S
    Nihon Geka Gakkai Zasshi; 1992 May; 93(5):505-17. PubMed ID: 1614394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of the male-specific hepatic microsomal steroid 16 alpha-hydroxylase, cytochrome P-450UT-A, in rats with portal bypass. Relevance to estradiol accumulation and impaired drug metabolism in hepatic cirrhosis.
    Cantrill E; Murray M; Mehta I; Farrell GC
    J Clin Invest; 1989 Apr; 83(4):1211-6. PubMed ID: 2703529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotransformation of estradiol by explant culture of human mammary tissue.
    Telang NT; Axelrod DM; Wong GY; Bradlow HL; Osborne MP
    Steroids; 1991 Jan; 56(1):37-43. PubMed ID: 2028481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 16-Hydroxylation of estrogens in pigmented and albino guinea-pigs.
    Hobkirk R; Mori J; Nilsen M
    J Steroid Biochem; 1980 Aug; 13(8):945-50. PubMed ID: 7464140
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of isotopes and LC-MS-ESI-TOF for mechanistic studies of tienilic acid metabolic activation.
    Belghazi M; Jean P; Poli S; Schmitter JM; Mansuy D; Dansette PM
    Adv Exp Med Biol; 2001; 500():139-44. PubMed ID: 11764926
    [No Abstract]   [Full Text] [Related]  

  • 14. Pretranslational hormonal control of male-specific cytochrome P-450 16 alpha in rat liver.
    Ström A; Mode A; Morgan E; Gustafsson JA
    Biochem Soc Trans; 1987 Aug; 15(4):575-6. PubMed ID: 3678577
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diminished activity of testosterone-16-alpha hydroxylase in bovine liver microsomes].
    Depelchin BO
    Ann Rech Vet; 1984; 15(4):515-8. PubMed ID: 6529121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite.
    Bajpai M; Roskos LK; Shen DD; Levy RH
    Drug Metab Dispos; 1996 Dec; 24(12):1401-3. PubMed ID: 8971149
    [No Abstract]   [Full Text] [Related]  

  • 17. [Estradiol-2-hydroxylase activity in tumors of the corpus uteri and breast: the effect of smoking].
    Tsyrlina EV; Manikhas (Kolesnik) OS; Vasil'ev DA; Kovalenko IG; Bershteĭn LM
    Vopr Onkol; 2000; 46(3):306-10. PubMed ID: 10976277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2C9 is a principal low-affinity phenacetin O-deethylase: fluvoxamine is not a specific CYP1A2 inhibitor.
    Venkatakrishnan K; von Moltke LL; Greenblatt DJ
    Drug Metab Dispos; 1999 Dec; 27(12):1519-22. PubMed ID: 10627170
    [No Abstract]   [Full Text] [Related]  

  • 19. 4-Hydroxylation of estrogens as marker of human mammary tumors.
    Liehr JG; Ricci MJ
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3294-6. PubMed ID: 8622931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic polymorphism of steroidogenic enzymes and steroid receptor level in tumors of the reproductive system].
    Berstein LM; Zimarina TS; Tsyrlina EV; Kovalevskiĭ AIu; Imianitov EN
    Vopr Onkol; 2004; 50(2):169-73. PubMed ID: 15176218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.